Today: 8 February 2026
Subscribe
Browse Category

SGX:D05 News 15 January 2026 - 8 February 2026

iFAST share price drops 3% as markets shut; earnings next week in focus

iFAST share price drops 3% as markets shut; earnings next week in focus

iFAST shares fell 3.2% to S$9.64 in heavy trading Friday, closing near the day’s low as investors awaited FY2025 results due Feb. 12. The stock is about 13% below its 52-week high. iFAST recently agreed to buy a 30% stake in Financial Alliance for S$19.6 million, pending regulatory approval. Assets under administration stood at S$30.62 billion as of Sept. 30.
7 February 2026
·····
DBS stock slips as metals meltdown rattles Asia, with earnings next week in focus

DBS stock slips as metals meltdown rattles Asia, with earnings next week in focus

DBS Group shares fell 1.0% to S$58.58 Monday, tracking a broader decline in Asian bank stocks as metals sell-offs triggered forced selling. OCBC dropped 1.2% and UOB slipped 0.5%. Singapore’s Straits Times Index lost about 0.8%, weighed by banks. DBS reports fourth-quarter results Feb. 9, with investors watching for updates on loan growth, credit costs, and its S$8 billion capital return plan.
2 February 2026
··
Brent oil price jumps above $70 as Iran strike fears flare; traders eye OPEC+ and U.S. stocks

Brent oil price jumps above $70 as Iran strike fears flare; traders eye OPEC+ and U.S. stocks

Brent crude futures surged above $70 a barrel for the first time in four months on Thursday, driven by Middle East tensions and supply disruptions in Kazakhstan and the U.S. Brent touched $70.35 before easing to $69.79 by 1011 GMT. Traders cited fears of a U.S. strike on Iran and possible closure of the Strait of Hormuz. OPEC+ meets Feb. 1, with U.S. inventory data due Feb. 4.
29 January 2026
····
DBS share price near record highs as SGX bank rally cools, Fed decision ahead

DBS share price near record highs as SGX bank rally cools, Fed decision ahead

DBS Group Holdings shares hit a new 52-week high of S$59.57 before easing to S$59.40 in Wednesday afternoon trading, following a record close Tuesday. Phillip Securities downgraded DBS and OCBC to “neutral” after recent price gains, citing margin pressure from falling SORA rates. Traders await the U.S. Federal Reserve’s policy decision and DBS’s full-year results due Feb. 9.
28 January 2026
·
DBS share price ticks up as Singapore bank rally rolls on; what to watch next

DBS share price ticks up as Singapore bank rally rolls on; what to watch next

DBS shares closed up 1.15% at S$58.75 on Friday, trailing gains in UOB and OCBC, which pushed the Straits Times Index to record highs. Macquarie Capital rated DBS “underperform” with a S$50 target, citing limited upside and exposure to Hong Kong property risks. DBS plans to redeem A$300 million in subordinated notes in April 2026, pending regulatory approval. Investors await policy updates from MAS on Jan. 29 and DBS earnings on Feb. 9.
23 January 2026
···
OCBC stock price ticks up as Bank of Singapore names new CFO and investors eye Feb 25 results

OCBC stock price ticks up as Bank of Singapore names new CFO and investors eye Feb 25 results

OCBC shares rose 0.1% to S$20.33 Tuesday, outperforming other major Singapore banks as DBS fell 0.8% and UOB slipped 0.3%. Bank of Singapore named Collins Chin as global CFO, effective immediately. OCBC allocated 42,747 treasury shares, worth about S$640,705, to employee schemes. The bank will report full-year 2025 results on Feb. 25 before market open.
20 January 2026
···
DBS share price holds near highs as analysts debate dividend trade and rate risk

DBS share price holds near highs as analysts debate dividend trade and rate risk

DBS shares closed at S$59.12 on Friday, up 0.39%, as Singapore bank stocks held steady ahead of the weekend. Analysts remain split on further upside, citing resilient dividends but warning that falling rates could pressure margins. Traders are watching for DBS’ Feb. 9 results and possible “significant risk transfer” deals as the next catalysts. OCBC ended at S$20.44 and UOB at S$36.74.
17 January 2026
····
DBS stock nears a 52-week high as investors weigh AI gains and the next dividend call

DBS stock nears a 52-week high as investors weigh AI gains and the next dividend call

DBS shares rose 0.8% to S$58.80 Thursday, just below their 52-week high, as investors assessed dividend prospects ahead of February results. The bank reported S$1 billion in “economic value” from AI in 2025, up from S$750 million in 2024. Analysts remain split on valuation and dividend sustainability amid rate concerns. Full-year earnings are due Feb. 9.
15 January 2026
···
1 2 3 4

Stock Market Today

LSEG share price heads into Monday after AI jitters hit London Stock Exchange Group stock

LSEG share price heads into Monday after AI jitters hit London Stock Exchange Group stock

8 February 2026
London Stock Exchange Group shares fell 1.1% to 7,502p Friday, closing out a third straight weekly decline and an 8% drop for the week. The selloff followed renewed concerns over AI disruption after a new Claude plug-in from Anthropic and caution over Big Tech’s AI spending. LSEG bought back 256,419 shares on Feb. 5. Investors await Monday’s open and LSEG’s FY25 results webcast on Feb. 26.
Anglo American share price slips after BofA downgrade as De Beers review looms

Anglo American share price slips after BofA downgrade as De Beers review looms

8 February 2026
Anglo American shares closed at 3,435 pence on Friday, down 0.75%, after BofA Global Research downgraded the miner to “neutral” over valuation and execution risks. The bank raised its price target to 3,600 pence but flagged a long wait for Teck synergies and uncertainty around De Beers. Investors await full-year results and updates on deals and disposals on Feb. 20.
GSK stock price: EU nod for Nucala in COPD puts the focus on Monday trade

GSK stock price: EU nod for Nucala in COPD puts the focus on Monday trade

8 February 2026
GSK shares closed Friday up 0.8% at 2,198 pence after the EU approved expanded use of Nucala for adults with uncontrolled COPD. Chairman Jonathan Symonds bought 2,500 shares earlier in the week. The stock is up 17% over the past week and nearly 49% in 12 months. GSK trades ex-dividend on Feb. 19.
Go toTop